Biotech

Medworxx Solutions Inc. Announces Shareholder Approval of Plan of Arrangement

TORONTO, ONTARIO: ...

Titan Pharmaceuticals Announces Uplisting to NASDAQ

SOUTH SAN FRANCISCO, CA: ...

Sermonix Receives Two Awards at the North American Menopause Society Annual Meeting

COLUMBUS, OH: Research on the Company's Investigational Drug, Lasofoxifene, Takes First Place Among Scientific Posters ...

Avita Medical Gains CE Mark for ReGenerCell(R) and ReNovaCell(R) to Complete Skin Healing Portfolio

NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM: Certification Applies to ReCell(R), ReGenerCell(R) and ReNovaCell(R) ...

Flamel Ireland Limited Licenses LiquiTime(R) Technology to Perrigo for U.S. Over-the-Counter Market

LYON, FRANCE: ...

Theravance Biopharma to Present New Retrospective Clinical Data on VIBATIV(R) (telavancin) Showing Positive Outcomes for Patients With Difficult-to-Treat Infections, Including MRSA, at IDWeek 2015

DUBLIN, IRELAND: Positive Study Results Support Company's Current Development and Regulatory Efforts for VIBATIV ...

Scott Kellen Appointed Chief Financial Officer of Sun BioPharma

MINNEAPOLIS, MN: Healthcare Executive Brings Extensive Public Company Financial Experience to Leadership Team ...

ProMetic Reports Successful PBI-4050 Pre-IND Meeting with the US FDA for Idiopathic Pulmonary Fibrosis ("IPF")

LAVAL, QUEBEC: - ProMetic allowed to proceed with filing of IND for pivotal study ahead of anticipated timelines - PBI-4050 to be added in combination to commercially available drugs in pivotal study ...

Medifocus, Inc. Announces Approach of Major Milestone of 100,000 Prolieve(R) Treatments

COLUMBIA, MD and TORONTO, ON: Prolieve(R) Is a Novel Combinational Treatment for Benign Prostatic Hyperplasia (BPH) ...

New Chinese iBioModulator(TM) Patent Joins iBio Vaccine Portfolio

NEW YORK, NY: ...